441 related articles for article (PubMed ID: 11685275)
21. Treatment of photoaging with topical aminolevulinic acid and light.
Alam M; Dover JS
Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):7-9. PubMed ID: 15657634
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
23. Microneedling Prior to Levulan PDT for the Treatment of Actinic Keratoses: A Split-Face, Blinded Trial.
Spencer JM; Freeman SA
J Drugs Dermatol; 2016 Sep; 15(9):1072-4. PubMed ID: 27602968
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents.
de Leeuw J; van der Beek N; Bjerring P; Neumann HA
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):460-9. PubMed ID: 19796088
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer.
Garcia-Zuazaga J; Cooper KD; Baron ED
Expert Rev Anticancer Ther; 2005 Oct; 5(5):791-800. PubMed ID: 16221049
[TBL] [Abstract][Full Text] [Related]
26. Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy.
Rivard J; Ozog D
J Drugs Dermatol; 2006 Jun; 5(6):556-61. PubMed ID: 16774110
[TBL] [Abstract][Full Text] [Related]
27. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
[TBL] [Abstract][Full Text] [Related]
28. Split-face-study using two different light sources for topical PDT of actinic keratoses:non-inferiority of the LED system.
Babilas P; Travnik R; Werner A; Landthaler M; Szeimies RM
J Dtsch Dermatol Ges; 2008 Jan; 6(1):25-32. PubMed ID: 17995967
[TBL] [Abstract][Full Text] [Related]
29. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
Galitzer BI
J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
[TBL] [Abstract][Full Text] [Related]
30. Cellulitis as a postprocedural complication of topical 5-aminolevulinic acid photodynamic therapy in the treatment of actinic keratosis.
Wolfe CM; Hatfield K; Cognetta AB
J Drugs Dermatol; 2007 May; 6(5):544-8. PubMed ID: 17679192
[TBL] [Abstract][Full Text] [Related]
31. Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
McLoone N; Donnelly RF; Walsh M; Dolan OM; McLoone S; McKenna K; McCarron PA
Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):183-90. PubMed ID: 18717959
[TBL] [Abstract][Full Text] [Related]
32. Severe cutaneous reaction to photodynamic therapy with blue light.
Moore MM; Reyna C; Hope RH
J Drugs Dermatol; 2011 Sep; 10(9):1057-8. PubMed ID: 22052277
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study.
Jeffes EW; McCullough JL; Weinstein GD; Fergin PE; Nelson JS; Shull TF; Simpson KR; Bukaty LM; Hoffman WL; Fong NL
Arch Dermatol; 1997 Jun; 133(6):727-32. PubMed ID: 9197826
[TBL] [Abstract][Full Text] [Related]
34. 5-aminolevulinic acid photodynamic therapy: where we have been and where we are going.
Gold MH; Goldman MP
Dermatol Surg; 2004 Aug; 30(8):1077-83; discussion 1083-4. PubMed ID: 15274696
[TBL] [Abstract][Full Text] [Related]
35. Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source.
Gold MH; Bradshaw VL; Boring MM; Bridges TM; Biron JA; Lewis TL
J Drugs Dermatol; 2004; 3(6 Suppl):S6-9. PubMed ID: 15624735
[TBL] [Abstract][Full Text] [Related]
36. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
[TBL] [Abstract][Full Text] [Related]
37. The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy.
Apalla Z; Sotiriou E; Panagiotidou D; Lefaki I; Goussi C; Ioannides D
Photodermatol Photoimmunol Photomed; 2011 Aug; 27(4):181-5. PubMed ID: 21729165
[TBL] [Abstract][Full Text] [Related]
38. Prospective, case-based assessment of sequential therapy with topical Fluorouracil cream 0.5% and ALA-PDT for the treatment of actinic keratosis.
Martin G
J Drugs Dermatol; 2011 Apr; 10(4):372-8. PubMed ID: 21455547
[TBL] [Abstract][Full Text] [Related]
39. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
